Netting Neutrophils Activate Autoreactive B Cells in Lupus. 2018

Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
Department of Dermatology, Lausanne University Hospital, CH-1011 Lausanne, Switzerland; and.

Lupus erythematosus (LE) patients develop autoantibodies that form circulating immune complexes (ICs) with extracellular self-nucleic acids. These ICs are deposited into peripheral tissues, where they trigger detrimental organ inflammation. Recent evidence suggests that ICs contain LL37-DNA complexes derived from neutrophil extracellular traps (NETs) and that LE patients develop pathogenic autoantibodies against these structures, including Abs to LL37. However, the mechanism that leads to the generation of these Abs is unknown. In this study, we show that NETs directly trigger Ab production by human memory B cells. This occurs via LL37-DNA complexes present in NETs, which have the unique ability to gain access to endosomal compartments of B cells and to trigger TLR9 activation. In LE patients, NET-derived LL37-DNA complexes trigger polyclonal B cell activation via TLR9, but also specifically expand self-reactive memory B cells producing anti-LL37 Abs in an Ag-dependent manner. These findings suggest a unique link between neutrophils and B cells in which NETs trigger a concerted activation of TLR9 and BCR leading to anti-NET autoantibody production in lupus.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D051217 Toll-Like Receptor 9 A pattern recognition receptor that binds unmethylated CPG CLUSTERS. It mediates cellular responses to bacterial pathogens by distinguishing between self and bacterial DNA. CD289 Antigen,TLR9 Protein,TLR9 Receptor,Antigen, CD289,Receptor, TLR9,Toll Like Receptor 9
D054804 Cathelicidins Antimicrobial cationic peptides with a highly conserved amino terminal cathelin-like domain and a more variable carboxy terminal domain. They are initially synthesized as preproproteins and then cleaved. They are expressed in many tissues of humans and localized to EPITHELIAL CELLS. They kill nonviral pathogens by forming pores in membranes. ALL-38 Peptide,Antibacterial Peptide LL-37,Antimicrobial Peptide LL-37,Bac4 Protein, Bos taurus,CAP18 Lipopolysaccharide-Binding Protein,CATH-1 Protein,Cathelicidin,Cathelicidin 1,Cathelicidin Antimicrobial Peptide,Cathelicidin LL-37,Cathelicidin-1,Cathelin-Like Protein,Cathelin-Related Antimicrobial Peptide,LL-37 Antibacterial Peptide,LL-37 Peptide,Myeloid Cathelicidin 1 Protein, Equus caballus,Ropocamptide,eCATH-1,hCAP-18,CAP-18,CAP18,FA-LL-37,K9CATH,eCATH-1 protein, Equus caballus,ALL 38 Peptide,Antibacterial Peptide LL 37,Antibacterial Peptide, LL-37,Antimicrobial Peptide LL 37,Antimicrobial Peptide, Cathelin-Related,CAP 18,CAP18 Lipopolysaccharide Binding Protein,CATH 1 Protein,Cathelicidin LL 37,FA LL 37,LL 37 Antibacterial Peptide,LL 37 Peptide,LL-37, Antibacterial Peptide,LL-37, Antimicrobial Peptide,LL-37, Cathelicidin,Lipopolysaccharide-Binding Protein, CAP18,Peptide LL-37, Antibacterial,Peptide LL-37, Antimicrobial,Peptide, ALL-38,Peptide, Cathelin-Related Antimicrobial,Peptide, LL-37,Peptide, LL-37 Antibacterial,Protein, CAP18 Lipopolysaccharide-Binding,Protein, CATH-1,Protein, Cathelin-Like,eCATH 1,eCATH 1 protein, Equus caballus,hCAP 18

Related Publications

Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
July 1984, Journal of immunology (Baltimore, Md. : 1950),
Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
November 2020, Cell reports,
Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
September 2018, Cell,
Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
January 2017, Proceedings of the National Academy of Sciences of the United States of America,
Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
October 1996, Journal of immunology (Baltimore, Md. : 1950),
Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
November 2023, The Journal of experimental medicine,
Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
November 2023, The Journal of experimental medicine,
Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
July 1996, Clinical immunology and immunopathology,
Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
January 2024, bioRxiv : the preprint server for biology,
Nicolas Gestermann, and Jeremy Di Domizio, and Roberto Lande, and Olivier Demaria, and Loredana Frasca, and Laurence Feldmeyer, and Julie Di Lucca, and Michel Gilliet
September 2011, Nature reviews. Immunology,
Copied contents to your clipboard!